BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 29, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 21, 2009
View Archived Issues
Centocor Ortho Biotech begins phase I study of psoriasis treatment CNTO-1959
Read More
H5N1 influenza virus vaccine from Vaxin induces strong antibody responses in first clinical trial
Read More
Human Genome Sciences and GSK report pivotal trial data for Benlysta
Read More
FDA accepts for review Spectrum's response on Zevalin as a Class 1 submission
Read More
Novel anti Abeta20-42 globulomer antibody, A-887755, under development for AD
Read More
Carvedilol shows preclinical potential and enters clinical evaluation for Alzheimer's disease
Read More
Novel Raf kinase inhibitors disclosed by the ICR and CRT
Read More
Roche presents novel P2X2 and P2X2/3 receptor antagonists
Read More
Cardax nominates lead candidate, Heptax, that addresses metabolic syndrome
Read More
Novel AMPK activators emerge from Rigel Pharmaceuticals R&D
Read More
Nycomed submits NDA to the FDA for Daxas in COPD
Read More
Seoul National University and AmorePacific present novel SPC modulators
Read More
SeneXta receives FDA IND approval for phase I SNX-001 trial
Read More
FDA approves revisions to Erbitux U.S. product labeling in colorectal cancer
Read More
Novel angiotensin II receptor blocker R-147176 reduces infarct volume in models of stroke
Read More
Respiratory syncytial virus vaccine candidate prevents replication in mouse lungs
Read More
FDA to review NDA for APF-530 in chemotherapy-induced nausea and vomiting
Read More
Orexigen reports Contrave data from three phase III trials in obesity
Read More
AlphaVax completes process development and preclinical studies of their H1N1 vaccine
Read More
FDA approves revisions to prescribing information for Amgen's EGFr antibody Vectibix
Read More
Evaluation agreement for the development and commercialization of TPR-100
Read More
Ardea commences phase IIb trial of RDEA-594 for gout
Read More
INNO-206 shown to inhibit pancreatic cancer growth in animal trials
Read More
Data reported from DURATION-3 trial comparing exenatide to Lantus in diabetes
Read More
Data Monitoring Committee reviews phase III Hematide program
Read More
